An international research team led by the Medical University of Vienna has investigated a new peptide derived from cone snail venom that significantly reduced inflammation-induced pain in an animal model. Crucially, its effect takes hold immediately after subcutaneous injection, whereas previously known cone snail peptides must be administered directly into the cerebrospinal fluid.